Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109439 | PMC |
| http://dx.doi.org/10.3389/fonc.2020.00377 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reflections on the current position and future trends in immunoglubulin therapy.
Transfus Apher Sci
October 2024
International Consultancy in Modern Precision Personalized Blood Component Therapies, London, England, UK. Electronic address:
Editorial comments: Two clinical viewpoints from Oslo.
Transfus Apher Sci
August 2024
International Consultancy in Modern Precision Personalized Blood Component Therapies, London, England, UK. Electronic address:
Spotlight on the knowledge economy in transfusion medicine: Where are we now!
Transfus Apher Sci
April 2024
TAS Senior Editor, International Consultancy in Modern Precision Personalized Blood Component Therapies, London, England, UK. Electronic address:
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize.
Front Oncol
March 2020
Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia.
Age-related Disease: A Revolution is Coming, Part 2-Dietary Acid Load, Hypertension, and Cardiovascular Disease.
Integr Med (Encinitas)
June 2018
We are starting to develop the analytical tools to examine damage to our DNA and screen for the presence of clonal hematopoiesis of indeterminate potential. This type of technology will soon support the personalization of approaches to both the prevention and treatment of age-related diseases, which have historically been characterized as beyond our control. We are at the start of an era that will one day be looked upon as the age of precision personalized lifestyle health care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!